HITRUST Risk-based, 2-year (r2) Certification validates Aegis Sciences Corporation continues its commitment to strong cybersecurity and meeting key regulations to...
The study, Evidence of Missed Novel Psychoactive Substances (NPS) in Unexpected Fentanyl Positives, by Aegis Sciences Corporation was recognized by the AACC...
Aegis Sciences Corporation has achieved great success with its sales and service according to our latest Client Satisfaction Survey. Our...
NASHVILLE, Tenn., July 1, 2023 – Aegis is pleased to announce that following a rigorous review process, it will continue to...
NASHVILLE, Tenn., March 6, 2023 – Regina Sweeney, Vice President of Client Relations, Aegis Sciences Corporation has been presented with a Bronze...
CLEVELAND, Ohio, February 7, 2023 – Quadax, Inc., a leading provider of healthcare revenue cycle management technology and services commenced a...
Sign up for the Aegis Newsletter